Previous studies have identified that there is a chimeric oncogene involving the tropomyosin 3 (TPM3) gene and a specific genomic locus of NTRK1 in colorectal cancer (CRC) patients [4,5]. This evidence concerns the gene TPM3 and colorectal carcinoma.